/Investor DB

6 Dimensions Capital — 2026 Investments

1 investments dated 2026 · listed companies and verified rows first · show all

Tamarind Biotamarind.bioin𝕏Series A · Feb 2026 · $14M

Tamarind provides a computational platform for protein and molecular engineering, offering AI and physics-based tools to design antibodies, peptides, enzymes, and small molecules.

AI & Machine LearningBiotechDeep TechEnterprise SoftwareSaaSSan Francisco, US

Deniz Kavi(Co-founder & CEO)inSherry Liu(Founder)in

Co-investorsTranspose Platform ManagementTreeo VCY Combinator468 CapitalDimension CapitalEight Capital+2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.